Search for diagnostic microRNAs for brain tumor identification using a low-temperature plasma bank
Open Access
- 23 January 2026
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (11) , 4565
Abstract
Aim . To assess the level of circulating small non-coding ribonucleic acids (microRNAs), previously identified as differentially expressed in next-generation sequencing (NGS) profiles of various brain tumor types, using a validation cohort formed from a low-temperature plasma bank. Material and methods . Plasma bioarchiving was performed on patients treated for brain tumors at the National Medical Research Center of Oncology from April 2018 to December 2024. Reverse transcription-polymerase chain reaction (RT-PCR) was used to determine the levels of 10 microRNAs in plasma samples from 40 individuals. Participants were divided into five groups of eight individuals as follows: those diagnosed with glioblastoma, astrocytoma, oligodendroglioma, benign meningioma, and healthy controls. The study groups included 17 women and 15 men, with a median age of 52,5 years. The control group included seven women and one man, with a median age of 53 years. Results . Plasma levels of miR-30c-5p, miR-128-3p, miR-186-5p, miR-194-5p, miR-484, miR-19b-3p, miR-431-5p, miR-3168, let-7c-5p, and miR-363-3p were determined using NGS data from 58 plasma samples (Gvaldin, 2024). The validation cohort revealed differential expression changes for four microRNAs (miR-128-3p, miR-194-5p, miR-19b-3p, and miR-363-3p) across the study groups. Conclusion . Differential expression of circulating miR-128-3p, miR-194-5p, miR-19b-3p, and miR-363-3p is associated with brain tumor oncogenesis and can be used for their diagnosis.Keywords
This publication has 23 references indexed in Scilit:
- MiR-128-3p – a gray eminence of the human central nervous systemMolecular Therapy Nucleic Acids, 2024
- A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsThe Lancet Oncology, 2023
- Oncogenic role of microRNA-19b-3p-mediated SOCS3 in glioma through activation of JAK-STAT pathwayMetabolic Brain Disease, 2022
- Emerging role of extracellular vesicles in the pathogenesis of glioblastomaMetabolic Brain Disease, 2022
- Liquid biopsy in gliomas: A RANO review and proposals for clinical applicationsNeuro-Oncology, 2022
- miR‐363‐3p induces EMT via the Wnt/β‐catenin pathway in glioma cells by targeting CELF2Journal of Cellular and Molecular Medicine, 2021
- Long noncoding RNA HNF1A‐AS1 regulates proliferation and apoptosis of glioma through activation of the JNK signaling pathway via miR‐363‐3p/MAP2K4Journal of Cellular Physiology, 2020
- Functional mechanisms of miR‐192 family in cancerGenes, Chromosomes and Cancer, 2020
- LncRNA PCED1B‐AS1 activates the proliferation and restricts the apoptosis of glioma through cooperating with miR‐194‐5p/PCED1B axisJournal of Cellular Biochemistry, 2019
- The Ultimate qPCR Experiment: Producing Publication Quality, Reproducible Data the First TimeTrends in Biotechnology, 2019